In one in vitro study, an antibody specific to interleukin-13 receptor alpha 2 (IL-13Rα2) (a receptor up-regulated in glioma cells) was attached to the surface of nanoparticles and demonstrated tumor specificity and toxicity in U373 and U87 glioma cell lines [69]. Here, IL13RA2 is linked to central nervous system cancer.